2025 MaTOS Breast | Strategies to Treat High Risk HR+, HER2 - Residual Disease (CDKi, IO, ADCs?)
Overview
NA
Target Audience
NA
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Lajos Pusztai, MD
Date of Release
May 14th, 2025
-1750785566843.webp&w=3840&q=75)
